- Home
- Applications
- namibia
- drug treatment
Show results for
Refine by
Drug Treatment Product Applications Available In Namibia
13 applications found
Dasabuvir is an antiviral drug for the treatment of hepatitis C. It inhibits hepatitis C virus (HCV) non-nucleoside NS5B palm polymerase to suppress RNA replicase. https://www.bocsci.com/dasabuvir-cas-1132935-63-7-item-462255.html ...
ByAlfa Chemistry based in NY, NEW YORK (USA)
Where does viscosity fit when it comes to the Pharmaceutical and Biotechnology Industry?. Protein-based drugs are the fastest growing class of drugs for the treatment of many diseases in humans, ranging from cancer to Alzheimer’s disease. ...
ByRheoSense Inc based in San Ramo, CALIFORNIA (USA)
To date, the FDA has not approved any drug for the treatment of the negative symptoms of schizophrenia, and from the clinical data available it does not appear as though existing drugs – even new generation drugs – represent a significant improvement in this area. It should be stressed that in addition to the progressive decline in quality of life, the negative symptoms can even hamper psychological and psychiatric ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Acute gastroenteritis and gastritis are characterized by inflammation of the mucus membranes of the gastrointestinal tract, most commonly caused by viral infection, with symptoms including nausea, vomiting, diarrhea and abdominal ...
ByRedHill Biopharma Ltd. based in Tel-Aviv, ISRAEL
Simplifying The Complexities of Modern Health ...
ByNantHealth, Inc. based in Morrisville, NORTH CAROLINA (USA)
Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ensuring proper clearance from the brain have hindered the use of antibody drugs for the treatment of neurological diseases. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
In this example, the aggregation of magnetic nanoparticles labeled with DiR is monitored in real time. Tumor microvasculature is labeled using ...
ByMauna Kea Technologies based in Paris, FRANCE
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular diseases. At present, more than 7,000 rare diseases have been found in humans, about 60% of which are neurological ...
ByRareStone Group based in Shanghai, CHINA
Deep Transcranial Magnetic Stimulation (Deep TMS™) is the only TMS system FDA-cleared to safely and effectively reduce comorbid anxiety symptoms in adult patients with depression, also known as anxious ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Modern medical treatments increasingly utilise drug therapy in addition to, or in place of, invasive measures. ...
ByJacobi Group based in Kalmar, SWEDEN
The development of highly cytotoxic drugs is needed for the success of the treatment in tumor cells. Paradoxically, the high toxicity limits its efficacy and application in vivo, causing damage to non-target organs and severe secondary effects. The use of directed liposomes has allowed the advance of many cancer drugs to preclinical and clinical trials, reducing side effects, and increasing their therapeutic index at the same time. More than 15 cancer liposomed ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Functional ultrasound (fUS) imaging is emerging as a powerful tool in neuropharmacology to study the effects of drugs on brain activity. Unlike fMRI, fUS offers increased sensitivity and compatibility with awake animal models, providing an unbiased view of drug interactions with neural substrates. ...
ByIconeus based in Paris, FRANCE
The application of DNA-based therapy mainly includes DNA-encoded compound library for new drugs research, genetically engineered bacterias drugs, nuelic acid vaccines, recombinant antibodies, small nucleic acid drugs, and gene editing. Firstly, we can quickly promote the development of new drugs through the construction of DNA coding libraries. Secondly, we can realize the mass production of protein drugs, antibiotic ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)